TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED financial statements, including revenue, expenses, profit, and loss

The total revenue of 600329 for the last quarter is 2.06 B CNY, and it's 14.16% lower compared to the previous quarter. The net income of Q1 24 is 387.33 M CNY.